Table 3.
Vol-T (mL) | Vol-E (mL) | Vol-E/Vol-T | nFA-T | nADC-T | nFA-E | nADC-E | nCBF-T | nCBV-T | nCBF-E | nCBV-E | |
---|---|---|---|---|---|---|---|---|---|---|---|
Chi-square | 2.562 | 7.337 | 10.522 | 4.760 | 12.876 | 2.656 | 8.928 | 18.211 | 13.453 | 7.791 | 4.619 |
P-value < | 0.278 | 0.026 | 0.005 | 0.093 | 0.002 | 0.265 | 0.012 | 0.001 | 0.001 | 0.020 | 0.099 |
Abbreviations: HGG, high-grade gliomas; LGG, low-grade gliomas; MET, metastases; nFA-T, normalized fractional anisotropy-tumor; nADC-T, normalized-ADC-tumor; nFA-E, normalized fractional anisotropy-edema; nADC-E, normalized-ADC-edema; nCBF-T, normalized cerebral blood flow-tumor; nCBV-T, normalized cerebral blood volume-tumor; nCBF-E, nCBF-edema; nCBV-E, nCBV-edema.
Significance set at P-value <.05.